- Home
- MPAA vs VIGL Comparison
MPAA vs VIGL Comparison
Compare MPAA & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPAA
- VIGL
- Stock Information
- Founded
- MPAA 1968
- VIGL 2020
- Country
- MPAA United States
- VIGL United States
- Employees
- MPAA N/A
- VIGL N/A
- Industry
- MPAA Auto Parts:O.E.M.
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- MPAA Consumer Discretionary
- VIGL Health Care
- Exchange
- MPAA Nasdaq
- VIGL Nasdaq
- Market Cap
- MPAA 138.3M
- VIGL 125.3M
- IPO Year
- MPAA 1994
- VIGL 2022
- Fundamental
- Price
- MPAA $6.19
- VIGL $3.62
- Analyst Decision
- MPAA
- VIGL Buy
- Analyst Count
- MPAA 0
- VIGL 5
- Target Price
- MPAA N/A
- VIGL $16.60
- AVG Volume (30 Days)
- MPAA 93.4K
- VIGL 99.8K
- Earning Date
- MPAA 11-07-2024
- VIGL 11-05-2024
- Dividend Yield
- MPAA N/A
- VIGL N/A
- EPS Growth
- MPAA N/A
- VIGL N/A
- EPS
- MPAA N/A
- VIGL N/A
- Revenue
- MPAA $727,866,000.00
- VIGL N/A
- Revenue This Year
- MPAA $8.91
- VIGL N/A
- Revenue Next Year
- MPAA $6.99
- VIGL N/A
- P/E Ratio
- MPAA N/A
- VIGL N/A
- Revenue Growth
- MPAA 7.23
- VIGL N/A
- 52 Week Low
- MPAA $4.36
- VIGL $2.47
- 52 Week High
- MPAA $10.40
- VIGL $9.24
- Technical
- Relative Strength Index (RSI)
- MPAA 45.84
- VIGL 54.21
- Support Level
- MPAA $6.41
- VIGL $3.30
- Resistance Level
- MPAA $6.40
- VIGL $3.63
- Average True Range (ATR)
- MPAA 0.33
- VIGL 0.16
- MACD
- MPAA -0.08
- VIGL 0.03
- Stochastic Oscillator
- MPAA 7.63
- VIGL 77.79
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard parts in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.